Industry News
Pharmaceutical Industry News
CMS’ Biogen decision could spell problems for Lilly, Roche Alzheimer’s drugs, half of surveyed neurologists say
CMS' Biogen decision could spell problems for Lilly, Roche Alzheimer's drugs, half of surveyed neurologists say badams Tue, 02/01/2022 - 04:55
Teva survey finds COVID has ‘widened the chasm’ on health disparities
Teva survey finds COVID has 'widened the chasm' on health disparities nmissakian Mon, 01/31/2022 - 20:27
Novavax finally submits its COVID-19 vaccine to the FDA. Is it too late?
Novavax finally submits its COVID-19 vaccine to the FDA. Is it too late? esagonowsky Mon, 01/31/2022 - 15:28
AbbVie’s new migraine meds could each pull in $2B at peak thanks to class growth, analyst says
AbbVie's new migraine meds could each pull in $2B at peak thanks to class growth, analyst says kdunleavy Mon, 01/31/2022 - 13:24
FDA commissioner nominee Califf makes ethics pledge to Sen. Warren in bid for her support: report
FDA commissioner nominee Califf makes ethics pledge to Sen. Warren in bid for her support: report fkansteiner Mon, 01/31/2022 - 12:54
FDA commissioner nominee Califf makes ethics pledge to Warren in bid for her support: report
FDA commissioner nominee Califf makes ethics pledge to Warren in bid for her support: report fkansteiner Mon, 01/31/2022 - 12:54
Two Biogen board members depart as company struggles to get Aduhelm off the ground
Two Biogen board members depart as company struggles to get Aduhelm off the ground fkansteiner Mon, 01/31/2022 - 10:30
2 Biogen board members depart as company struggles to get Aduhelm off the ground
2 Biogen board members depart as company struggles to get Aduhelm off the ground fkansteiner Mon, 01/31/2022 - 10:30
Roche, with an FDA nod for Vabysmo in hand, looks to challenge Regeneron’s dominant Eylea
Roche, with an FDA nod for Vabysmo in hand, looks to challenge Regeneron's dominant Eylea kdunleavy Mon, 01/31/2022 - 09:52
FDA issues 3 observations to Granules India site in US after pre-approval inspection
FDA issues 3 observations to Granules India site in US after pre-approval inspection jkeenan Mon, 01/31/2022 - 09:42
FDA issues 3 observations to Granules India site in US after preapproval inspection
FDA issues 3 observations to Granules India site in US after preapproval inspection jkeenan Mon, 01/31/2022 - 09:42
Aurobindo subsidiary recalls one lot of injectable antibiotic after complaint of hair in vial
Aurobindo subsidiary recalls one lot of injectable antibiotic after complaint of hair in vial jkeenan Mon, 01/31/2022 - 09:02
AstraZeneca reveals insurance fraud probe in China as officials say they’ve made criminal arrests
AstraZeneca reveals insurance fraud probe in China as officials say they've made criminal arrests fkansteiner Mon, 01/31/2022 - 08:56
Skip your pants? Merck ramps up its ‘Don’t Skip’ TV vaccination campaign with Wade and Union
Skip your pants? Merck ramps up its 'Don't Skip' TV vaccination campaign with Wade and Union badams Mon, 01/31/2022 - 06:32
‘Digital sleuthing’ helps pharma connect with the right social media influencers
'Digital sleuthing' helps pharma connect with the right social media influencers nmissakian Fri, 01/28/2022 - 20:05
Eli Lilly, Incyte axe Olumiant in lupus amid eczema stalemate at FDA
Eli Lilly, Incyte axe Olumiant in lupus amid eczema stalemate at FDA fkansteiner Fri, 01/28/2022 - 10:33
Unable to ‘align’ with FDA, Regeneron, Sanofi pull application for Libtayo in cervical cancer days before decision date
Unable to 'align' with FDA, Regeneron, Sanofi pull application for Libtayo in cervical cancer days before decision date kdunleavy Fri, 01/28/2022 - 09:49
Fierce Pharma Asia—Samsung Biologics’ mRNA ambition, GSK COVID-19 vaccine supply; Fujifilm’s plant buy
Fierce Pharma Asia—Samsung Biologics' mRNA ambition, GSK COVID-19 vaccine supply; Fujifilm's plant buy aliu Fri, 01/28/2022 - 09:32
Eli Lilly, with Alzheimer’s top of mind, plots 300 jobs at new $445M manufacturing plant
Eli Lilly, with Alzheimer's top of mind, plots 300 jobs at new $445M manufacturing plant fkansteiner Fri, 01/28/2022 - 08:59
UPDATED: Eli Lilly to plow a total of $1.5B into 2 new manufacturing plants
UPDATED: Eli Lilly to plow a total of $1.5B into 2 new manufacturing plants fkansteiner Fri, 01/28/2022 - 08:59